These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 16860190

  • 1. Long-term treatment with EPO increases serum levels of high-density lipoprotein in patients with CKD.
    Siamopoulos KC, Gouva C, Katopodis KP, Tzallas C, Nikolopoulos P, Papavasiliou EC, Tselepis AD.
    Am J Kidney Dis; 2006 Aug; 48(2):242-9. PubMed ID: 16860190
    [Abstract] [Full Text] [Related]

  • 2. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC, Gouva C, Siamopoulos KC, Tselepis AD.
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [Abstract] [Full Text] [Related]

  • 3. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.
    J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
    [Abstract] [Full Text] [Related]

  • 4. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 5. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
    Spanakis E, Sidiropoulos P, Papadakis J, Ganotakis E, Katsikas G, Karvounaris S, Bizaki A, Kritikos H, Boumpas DT.
    J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
    [Abstract] [Full Text] [Related]

  • 6. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial.
    Teplan V, Schück O, Votruba M, Poledne R, Kazdová L, Skibová J, Malý J.
    Wien Klin Wochenschr; 2001 Sep 17; 113(17-18):661-9. PubMed ID: 11603100
    [Abstract] [Full Text] [Related]

  • 7. Enhanced metabolic effect of erythropoietin and keto acids in CRF patients on low-protein diet: Czech multicenter study.
    Teplan V, Schück O, Knotek A, Hajný J, Horácková M, Kvapil M, Czech multicenter study.
    Am J Kidney Dis; 2003 Mar 17; 41(3 Suppl 1):S26-30. PubMed ID: 12612947
    [Abstract] [Full Text] [Related]

  • 8. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J.
    Clin Exp Pharmacol Physiol; 2007 Apr 17; 34(4):347-9. PubMed ID: 17324148
    [Abstract] [Full Text] [Related]

  • 9. [Effect of erythropoietin therapy on serum lipoprotein levels in patients on hemodialysis].
    Kes P, Bobić I, Reiner Z, Ratković-Gusić I.
    Lijec Vjesn; 2002 May 17; 124(5):146-50. PubMed ID: 12152415
    [Abstract] [Full Text] [Related]

  • 10. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M, Collins D, Robins S, Bloomfield H, Curhan GC.
    Am J Kidney Dis; 2004 Nov 17; 44(5):832-9. PubMed ID: 15492949
    [Abstract] [Full Text] [Related]

  • 11. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep 17; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

  • 12. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M, Delibasi T, Kaya A, Aydogan T, Koca C, Akcay A, Duranay M, Yigitoglu R.
    Ren Fail; 2006 Sep 17; 28(7):567-71. PubMed ID: 17050239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Sep 17; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 15. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T, Laloi-Michelin M, Virally M, Peynet J, Giraudeaux V, Kévorkian JP, Guillausseau PJ.
    Eur J Intern Med; 2009 Mar 17; 20(2):197-200. PubMed ID: 19327612
    [Abstract] [Full Text] [Related]

  • 16. Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy.
    Sirken G, Kung SC, Raja R.
    ASAIO J; 2003 Mar 17; 49(4):422-5. PubMed ID: 12918584
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.